Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease

BioFactors

Volumn 33, Issue 2, 2008, Pages 99-106

  Salehi, Zivar ^a   Mashayekhi, Farhad ^a   Naji, Mohammad ^a  

^a UNIVERSITY OF GUILAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUMBAR PUNCTURE; NERVE CELL NECROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; BLOTTING, WESTERN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED;

EID: 65949096494     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520330202     Document Type: Article

References (32)

1. M.A. Aberg, N.D. Aberg, T.D. Palmer, A.M. Alborn, C. Carlsson-Skwirut, P. Bang, L.E. Rosengren, T. Olsson, F.H. Gage and P.S. Eriksson, IGF-I has a direct proliferative effect in adult hippocampal progenitor cells, Mol Cell Neurosci 24 (2003), 23-40.
2. D. Aguado-Llera, E. Arilla-Ferreiro, A. Campos-Barros, L. Puebla-Jimenez and V. Barrios, Protective effects of insulin like growth factor-I on the somatostatinergic system in the temporal cortex of beta-amyloid-treated rats, J Neurochem 92 (2005), 607-615.
3. S.J. Allen, G.K. Wilcock and D. Dawbarn, Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease, Biochem Biophys Res Commun 2 (1999), 648-651.
4. B. Anlar, K.A. Sullivan and E.L. Feldman, Insulin-like growth factor-I and central nervous system development, Horm Metab Res 31 (1999), 120-125.
5. Y. Cao, A.J. Gunn, L. Bennet, D. Wu, S. George, P.D. Gluckman, X.M. Shao and J. Guan, Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep, J Cereb Blood Flow Metab 23 (2003), 739-747.
6. E. Carro, J.L. Trejo, A. Núñez and I. Torres-Aleman, Brain repair and neuroprotection by serum insulin-like growth factor I, Mol Neurobiol 27 (2003), 153-162.
7. B. Connor and M. Dragunow, The role of neuronal growth factors in neurodegenerative disorders of the human brain, Brain Res Brain Res Rev 27 (1998), 1-39.
8. S. Doré, S. Bastianetto, S. Kar and R. Quirion, Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons, Ann N Y Acad Sci 890 (1999), 356-364.
9. S.R. Edmondson, G.A. Werther, A. Russell, D. LeRoith, C.T. Roberts, Jr. and F. Beck, Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: relationship to insulin-like growth factor-I mRNA, Endocrinology 136 (1995), 4602-4609.
10. C. Escartin, F. Boyer, A.P. Bemelmans, P. Hantraye and E. Brouillet, IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats, Neurosci Lett 425 (2007), 167-172.
11. E. Fernández, M.A. Martín, S. Fajardo, F. Escrivá and C. Alvarez, Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats, Am J Physiol Endocrinol Metab 6 (2007), 292-296.
12. I. Ferrer, C. Marín, M.J. Rey, T. Ribalta, E. Goutan, R. Blanco, E. Tolosa and E. Martí, BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies, J Neuropathol Exp Neurol 58 (1999), 729-739.
13. J. Gehrmann, J. Lannes-Vieira and H. Wekerle, Differential expression of fibroblast growth factor-2 and receptor by glial cells in experimental autoimmune encephalomyelitis (EAE), Glia 16 (1996), 93-100.
14. T. Hagg, Molecular regulation of adult CNS neurogenesis: an integrated view, Trends Neurosci 28 (2005), 589-595.
15. J.J. Hauw, D. Seilhean, F. Piette, T. Uchihara and C. Duyckaerts, Alzheimer's disease lesions: from morphology to cell biology, Bull Acad Natl Med 180 (1996), 1687-1700.
16. S. Humbert, E.A. Bryson, F.P. Cordelières, N.C. Connors, S.R. Datta, S. Finkbeiner, M.E. Greenberg and F. Saudou, The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt, Dev Cell 2 (2002), 831-837.
17. C.E. Johanson, J.E. Donahue, A. Spangenberger, E.G. Stopa, J.A. Duncan and H.S. Sharma, Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation, Acta Neurochir Suppl 96 (2006), 451-456.
18. C.E. Johanson, D.E. Palm, M.J. Primiano, P.N. McMillan, P. Chan, N.W. Knuckey and E.G. Stopa, Choroid plexus recovery after transient forebrain ischemia: role of growth factors and other repair mechanisms, Cell Mol Neurobiol 20 (2000), 197-216.
19. W.H. Lee, S. Javedan and C.A. Bondy, Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development, J Neurosci 12 (1992), 4737-4744.
20. D.A. Linseman, M.L. McClure, R.J. Bouchard, T.A. Laessig, F.A. Ahmadi and K.A. Heidenreich, Suppression of death receptor signaling in cerebellar Purkinje neurons protects neighboring granule neurons from apoptosis via an insulin-like growth factor I-dependent mechanism, J Biol Chem 27 (2002), 24546-24553.
21. W.J. Lukiw and N.G. Bazan, Survival signalling in Alzheimer's disease, Biochem Soc Trans 34 (2006), 1277-1282.
22. J.A. Miyan, M. Nabiyouni and M. Zendah, Development of the brain: a vital role for cerebrospinal fluid, Can J Physiol Pharmacol 81 (2003), 317-328.
23. M.G. Murer, Q. Yan and R. Raisman-Vozari, Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease, Prog Neurobiol 63 (2001), 71-124.
24. C. Nicholson, Signals that go with the flow, Trends Neurosci 22 (1999), 143-145.
25. C. Nilsson, B.M. Hultberg and S. Gammeltoft, Autocrine role of insulin-like growth factor II secretion by the rat choroid plexus, Eur J Neurosci 8 (1996), 629-635.
26. D. Offen, B. Shtaif, D. Hadad, A. Weizman, E. Melamed and I. Gil-Ad, Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease, Neurosci Lett 316 (3) (2001), 129-132.
27. J.R. O'Kusky, P. Ye and A.J. D'Ercole, Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development, J Neurosci 15 (2000), 8435-8442.
28. Z.B. Redzic and M.B. Segal, The structure of the choroid plexus and the physiology of the choroid plexus epithelium, Adv Drug Deliv Rev 14 (2004), 1695-1716.
29. V.C. Russo, P.D. Gluckman, E.L. Feldman and G.A. Werther, The insulin-like growth factor system and its pleiotropic functions in brain, Endocr Rev 26 (2005), 916-943.
30. D.J. Selkoe, Presenilin, Notch, and the genesis and treatment of Alzheimer's disease, Proc Natl Acad Sci U S A 98 (2001), 11039-11041.
31. R. Vanhala, U. Turpeinen and R. Riikonen, Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism, Dev Med Child Neurol 43 (2001), 614-616.
32. P. Ye, L. Li, R.G. Richards, R.P. DiAugustine and A.J. D'Ercole, Myelination is altered in insulin-like growth factor-I null mutant mice, J Neurosci 15 (2002), 6041-6051.